Integrated Cancer Research Seminar Series

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Tuesday October 15, 2013 - Wednesday October 16, 2013
      4:00 pm - 4:59 pm
  • Location: Parker H. Petit Institute for Bioengineering & Bioscience, Room 1128
  • Phone: (404) 894-6228
  • URL: http://www.ibb.gatech.edu
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact

John McDonald, PhD

Summaries

Summary Sentence: "Designed Multiple Ligands for Targeted Epigenetic Perturbation" - Yomi Oyelere, PhD, Georgia Tech

Full Summary: Integrated Cancer Research Seminar Series - "Designed Multiple Ligands for Targeted Epigenetic Perturbation" - Yomi Oyelere, PhD, Georgia Tech

"Designed Multiple Ligands for Targeted Epigenetic Perturbation" -

Yomi Oyelere, PhD
Associate Professor, School of Chemistry & Biochemistry
Georgia Tech

The overarching research objective of our laboratory is to delineate the chemical basis of the molecular recognition events employed by biomolecules to drive important biological processes. We are interested in how perturbation of molecular recognition, by natural and synthetic ligands, can be used to understand the molecular basis of biological processes. In the pursuit of our research, we find inspiration in the fact that the basic molecular recognition principles in globular RNAs and proteins are one and the same. In this line of thought, one of the primary research focuses of our laboratory is the use of common molecular template to design new ligands for RNA and protein targets. Histone deacetylases and ribosomes are the current targets in this project. The ligands that have resulted from these studies have been used to probe the molecular basis of the function of their respective targets. Also, many elicit practical and desirable bioactivities including anti-tumor and anti-infective activities. Furthermore, our laboratory is involved in an interdisciplinary collaboration with the El-Sayed’s group on the design of new organic ligand conjugated gold nanoparticles (AuNPs) for cell selective delivery. Individual research project in our laboratory involves a unique blend of the tools of synthetic organic chemistry, computational chemistry, biochemistry and molecular biology.

Related Links

Additional Information

In Campus Calendar
Yes
Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
No audiences were selected.
Categories
Seminar/Lecture/Colloquium
Keywords
IBB, ICRC Seminar
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Sep 3, 2013 - 6:37am
  • Last Updated: Oct 7, 2016 - 10:04pm